MEDIPOST Co., Ltd. (KOSDAQ:078160)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,420
+90 (0.87%)
Aug 8, 2025, 3:30 PM KST
0.87%
Market Cap352.24B
Revenue (ttm)71.85B
Net Income (ttm)-72.06B
Shares Out34.10M
EPS (ttm)-2,113.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume27,945
Average Volume50,269
Open10,420
Previous Close10,330
Day's Range10,000 - 10,500
52-Week Range5,510 - 15,180
Beta0.50
RSI40.95
Earnings DateAug 14, 2025

About MorphoSys AG

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 328
Stock Exchange KOSDAQ
Ticker Symbol 078160
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.